Skip to content
DOV

Dover Corporation

Dover Corporation Q2 FY2025 earnings call

July 24, 2025 · fiscal period ended 2025-06

EPS · actual vs est

$2.44 / $2.39Beat +2.1%

Revenue · actual vs est

$2.05B / $2.04BBeat +0.5%
Ask about this call

Summary

Generated 2025-07-24

Management highlights

  • Dover's second quarter results were strong, driven by excellent production performance, positive margin mix from growth platforms and prior period cost actions; top line performance accelerated with broad-based shipment growth and outperformance in end markets; order trends positive, up 7% year-over-year bolstering second half outlook with majority of third quarter revenue in backlog. - Margin performance exemplary with record adjusted segment EBITDA margins above 25% due to prior period portfolio actions, positive mix from growth platforms and cost containment/ productivity actions; adjusted EPS up 16% in the quarter. - Ongoing capital deployment actions, including investment in high ROI organic capital projects and completion of two acquisitions within Pumps & Process Solutions segment. - Second quarter consolidated bookings up 7% year-over-year and sequentially, with year-to-date book-to-bill above 1 across all 5 segments, particularly strong in high-margin and secular growth markets
View in transcript ↓

Segment performance

  1. Engineered Products: Revenue down in the quarter on lower volumes in vehicle services; saw improving sentiment in vehicle services, especially in North America where book-to-bill was north of 1%; margin performance up on structural cost management and productivity. 2. Clean Energy & Fueling: Up 8% in the quarter, led by strong shipments in clean energy components, fluid transport and North American retail software and equipment; margin performance solid, up 80 basis points on volume leverage, higher mix of below ground fueling equipment and restructuring benefit carry forward. 3. Imaging & ID: Stable on growth in core marking and coding business, partially offset with timing of textiles; margin performance exemplary at 28% adjusted EBITDA margin, with management actions on cost to serve and structural cost controls driving incremental margins higher. 4. Pumps & Process Solutions: Up 4% organically on double-digit growth in single-use biopharma components, thermal connectors for liquid cooling of data centers and digital controls of midstream natural gas compression; segment revenue performance, including acquisition of SIKORA and volume leverage drove margin improvement. 5. Climate Sustainability: Revenue down in the quarter on comparative declines in food retail cases and engineering services, but offset by record quarterly volumes in CO2 systems; heat exchangers up sequentially and year-over-year on record quarterly shipments in North America, with European heat pump heat exchanger shipments down slightly in the quarter but expected to inflect positively in the second half; segment posted 60 basis points of margin improvement against a difficult comp period on productivity actions and a higher mix of CO2 systems
View in transcript ↓

Guidance

  • Raised full year adjusted EPS guidance to $9.35 to $9.55, with midpoint plus 14% for the full year. - Free cash flow guidance remains on track at 14% to 16% of revenue on strong operating cash flow conversion. - Second quarter consolidated bookings up 7% year-over-year, with year-to-date book-to-bill above 1 across all segments, and majority of third quarter revenue already in backlog; July orders tracking well
View in transcript ↓

Risks

  • Macro-economic noise and uncertainty may impact demand. - Tariff uncertainty could lead to order pushouts, such as in Refrigeration non-CO2 portion where projects slid to the right. - Large projects may be delayed for various reasons, causing order drift
View in transcript ↓

Q&A highlights

Q: Mike Halloran with Baird asked about the trajectory through the quarter and changes in guidance.

A: Richard Tobin responded that margin performance was slightly above expectation, with growth platforms accretive to margins, and they are ahead of where they thought they would be, with decisions on Q4 production to be made based on bookings momentum and backlog.

Q: Chris Snyder with Morgan Stanley asked about competitive dynamics.

A: Richard Tobin said they are in a positive price-cost position, competing well with smaller competitors, but share dynamics are early to assess due to restocking in Q1.

Q: Steve Tusa with JPMorgan asked about margins.

A: Richard Tobin explained that incremental margins will come down due to mix, as the portfolio is more short cycle, and they focus on business-level contribution margin rather than total EBITDA margin.

Q: Nigel Coe with Wolfe Research asked about pricing in CST and biopharma.

A: Richard Tobin said CST margin is affected by mix, with room to improve, and biopharma is more in-use product consumption rather than new build margins.

Q: Andrew Obin with Bank of America asked about tariff impact on orders.

A: Richard Tobin said more pushouts in Refrigeration, especially non-CO2 portion, due to customer pressure.

Q: Jeff Sprague with Vertical Research Partners asked about restructuring.

A: Richard Tobin said the $30 million benefit this year, with at least $30 million next year, and timing of realization is important.

Q: Deane Dray with RBC Capital Markets asked about data center opportunity.

A: Richard Tobin said they are leaders in connectors and co-leaders in heat exchangers, with dedicated teams, but capacity build-out is uncertain.

Q: Brett Linzey with Mizuho asked about tariffs and reshoring.

A: Richard Tobin said on track with reshoring, and no additional tariff headwinds in Q3/Q4.

Q: Joe O'Dea with Wells Fargo asked about demand impact of tariff uncertainty.

A: Richard Tobin said some reticence in bigger projects but no overriding change in trajectory, with revenue growth driven by mix, comps, and FX.

Q: Julian Mitchell from Barclays asked about organic sales growth.

A: Richard Tobin said generally, with gradual acceleration, and decision on Q4 production based on bookings momentum.

Q: Scott Davis from Melius Research asked about M&A and portfolio growth.

A: Richard Tobin said they have $400 million in revenue under LOI, capital deployment important, and portfolio growth from organic R&D and portfolio optimization

View in transcript ↓

Key numbers

Reported versus consensus

Earnings calendar feed

MetricReportedConsensusDeltaPrior year
EPS$2.44$2.39+2.1%$2.36
Revenue$2.05B$2.04B+0.5%$2.18B

Transcript

July 24, 2025

Full transcript unavailable for redistribution

The structured summary above covers the available call sections. Full transcript text is not included on this page.

Continue exploring

Prior quarters

This page presents the stored structured earnings-call summary and deterministic earnings calendar values. How this is generated. For informational purposes only; not investment advice.